Overview: RBC Morphology TestIntroduction: The RBC Morphology Test assesses red blood cell shape to diagnose anemias or blood disorders, helping identify causes of fatigue or weakness. Affecting 1 in 10 people with anemia, RBC shape abnormalities pose diagnostic challenges due to diverse causes. Following 2023 American Society of Hematology (ASH) guidelines, it uses microscopy for high accuracy, supporting hematology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in hematology.
Other Names: RBC Shape Test, Erythrocyte Morphology Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: RBC morphology testing began in the 19th century with research by Ehrlich, who classified cell shapes. Microscopy advancements in the 1960s improved detection, surpassing earlier staining methods.
Purpose: Detects RBC shape abnormalities to diagnose anemias or blood disorders, guides iron therapy or transfusion, and evaluates patients with fatigue, aiming to manage disease.
Test Parameters: RBC shape abnormalities
Pretest Condition: No special preparation required. Collect whole blood. Report history of blood disorders.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document fatigue or weakness. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., heart failure), and sample collection risks.
Procedural Considerations: Uses microscopy to assess shape, requiring labs with skilled technicians. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter shape, requiring correlation.
Clinical Significance: Abnormal shapes suggest anemia or disorder, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal shapes may require other tests.
Specialist Consultation: Consult a hematologist for interpretation.
Additional Supporting Tests: CBC, iron studies, or hemoglobin electrophoresis to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False negatives possible with mild abnormalities.
References: ASH Guidelines, 2023; Blood, Ehrlich P, 2022.
